Indiqube Spaces IPO Day 3: Check GMP, Subscription Status & Key Highlights
The ₹700 crore Indiqube Spaces IPO opened on July 23, 2025, and is scheduled to close today, 25 July 2025. The basis of allotment will be finalised on Monday, July 27, 2025, and the tentative listing on BSE and NSE is July 30, 2025.
Indiqube Spaces IPO: Issue Details
- Issue Size: Indiqube Spaces IPO is a book-building issue of ₹700 crores, consisting of a fresh issue of ₹650 crores and an offer for sale of ₹50 crores.
- Price Band: The company has set the price band between ₹225 and ₹237 per share.
- Book-running lead managers: ICICI Securities Limited
- Registrar: MUFG Intime India Private Limited (Link Intime).
- Listing: The shares are proposed to be listed on the NSE and the BSE.
Click here to explore other Upcoming IPOs
Indiqube Spaces IPO Day 3: Subscription Details
[25-July-2025 10:48:00 PM]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers(QIBs) |
1.42 |
|
Non-Institutional Investors |
2.63 |
|
Retail Individual Investors(RIIs) |
8.46 |
|
Employees |
5.03 |
|
Total |
3.04 |
Also Read : Indiqube Spaces IPO Day 2 Subscription Status
Utilisation of IPO Proceeds
The company aims to use the net proceeds from the fresh issue towards the following objectives.
- Repay/prepay company’s outstanding borrowings
- Fund capital expenditure to establish new centres
- General corporate purposes
Click here to check out newly Listed IPOs
Indiqube Spaces IPO GMP Details
As of 25 July 2025, Indiqube Spaces IPO's GMP stood at ₹10. The estimated listing price is ₹247, i.e., a 4.22% gain per share over the upper price band.
Source: Business Standard Report dated 25 July 2025
Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here